Informed SkinMorpheus8

RF & Energy

Morpheus8

Fractional RF Microneedling

Delivers radiofrequency energy via microneedles to remodel subdermal tissue

Skin LaxitySagging JowlsLoss of CollagenAcne
Safe for skin types
Safe forFitzpatrick I–IV (with precautions)
Use cautionFitzpatrick V: increased PIH risk from thermal skin surface contact
Avoid ifFitzpatrick VI: high PIH risk; some guidelines advise against in darkest skin types

RF microneedling delivers energy subcutaneously but superficial skin contact still poses pigmentation risk for darker tones. Choosing a device with insulated needles (not bare-tip) reduces but does not eliminate the risk. Pre-treatment with a depigmenting agent is often recommended.

In plain English

Morpheus8 uses a grid of fine needles that deliver heat energy deep into the skin, which triggers the body's natural healing response and stimulates new collagen over the following months. It's commonly used for mild jowling, neck laxity, and body areas where the skin has become looser over time. You'll have some bruising and redness for a few days after each session, and a series of three treatments is usually recommended for the best outcome.

The science

Morpheus8 combines microneedling with fractional radiofrequency energy delivered through insulated needles, targeting the subdermal fat-skin junction at depths of 2–8mm. The RF energy coagulates subdermal tissue at the needle tips, stimulating a wound-healing response that remodels collagen and subcutaneous architecture. It is particularly marketed for jowl laxity, neck bands, and body applications. Results require 3–6 months to develop fully and a series of 3 sessions for optimal effect.

Why these scores
Medical PromiseHigher is better
6/10

DiBernardo et al. (2020) demonstrated measurable skin laxity improvement (mean 29% on a validated scale). Growing evidence base but fewer large RCTs; a significant proportion of published data is from manufacturer-funded single-centre trials.

Short-term SafetyHigher is safer
6/10

Microneedle channels create pinpoint bleeding; bruising and swelling for 3-5 days; post-procedure erythema 1-2 weeks. Burns from RF delivery are documented, particularly at high energy or shallow needle placement. Infection risk from microneedle penetration is low with correct post-care protocol.

Long-term SafetyHigher is safer
7/10

Adipose atrophy (permanent fat loss in the treated area) is a documented complication with aggressive settings or superficial tip placement, particularly in patients with thin subcutaneous fat. Burns causing scarring have been reported. Outcome surveillance beyond 2 years is limited in peer-reviewed literature.

Should You Try ThisHigher is better
6/10

A reasonable choice for mild-to-moderate laxity with less downtime than ablative lasers. Lower evidence quality than gold-standard options, and results are significantly operator- and device-settings-dependent.

Common misconceptions
Myth

Morpheus8 is a facelift equivalent

Reality

Morpheus8 produces collagen remodelling in the mid-dermal to subdermal plane; it cannot replicate the structural SMAS repositioning or skin excision of a surgical facelift. It is appropriate for mild-to-moderate laxity in patients who are not surgical candidates or prefer non-surgical options.

Myth

Morpheus8 has no PIH risk for any skin type

Reality

While RF energy does not interact with melanin the way laser does, PIH has been reported after Morpheus8, likely from the mechanical microneedling component and post-treatment inflammation. The claim of zero PIH risk for all skin types is not supported by complication reports.

Myth

Burns and fat atrophy only happen with fake devices

Reality

These complications are documented with genuine InMode Morpheus8 devices operated by licensed practitioners. They reflect parameter selection errors, not device authenticity issues.

What the evidence firmly supports
  • DiBernardo et al. (JDD 2020; n=53) prospective series showed 29% mean improvement in skin laxity on a validated 5-point scale at 3 months, with 87% of subjects showing measurable collagen remodelling on ultrasound. This is the most rigorous Morpheus8-specific dataset but is a single-centre, uncontrolled series funded by InMode.

  • Fractional RF microneedling as a class has a reasonable safety profile in Fitzpatrick types I-VI, with lower PIH risk than laser resurfacing because RF energy does not interact with melanin.

  • Adipose atrophy (permanent fat loss in the treated area) is a documented complication from overly aggressive settings or superficial needle placement. Case reports describe visible facial hollowing requiring filler correction. Risk is higher in patients with thin subcutaneous fat.

  • Burns and PIH from Morpheus8 have been reported in the literature and in adverse event registries, particularly with incorrect needle depth or high RF energy in thin-skinned areas. These complications occur with genuine InMode devices, not only counterfeit ones.

  • The DiBernardo et al. dataset is manufacturer-funded; independent replication in RCT format is lacking. A significant proportion of published Morpheus8 efficacy data comes from single-centre case series with no control group.

  • Nerve paresthesia and transient motor nerve dysfunction have been reported as rare complications, particularly with deep settings near the perioral or temporal regions.

Still being studied
  • ?

    Optimal parameter settings (energy level, needle depth, density) for different indications and tissue types, current protocols are largely experience-derived.

  • ?

    Long-term adipose effects of repeated high-energy Morpheus8 treatments have not been characterised beyond 2 years.

  • ?

    Whether adverse events including burns and fat atrophy are underreported given the predominantly manufacturer-funded evidence base.

  • ?

    Head-to-head comparison against surgical options for the specific laxity range where Morpheus8 is marketed.

Key Study

Fractional RF microneedling (Morpheus8) for improvement of skin laxity: a prospective, multi-center evaluation

DiBernardo et al. · Journal of Drugs in Dermatology · 2020

In a prospective series (n=53), blinded photographic assessment at 3 months post-treatment showed a mean 29% improvement in skin laxity on a validated 5-point scale, with 87% of subjects showing measurable collagen remodelling on ultrasound.

PubMed ↗  PMID 32741162
Products on the market
BrandManufacturerWhat differentiates itApprovalPricing
Morpheus8InMode24-pin fractional RF microneedling; FDA Cleared; adjustable depth 1–8mm; face and bodyFDA Cleared (510k)$800–$2,000/session
Genius RF (Lutronic)LutronicReal-time impedance measurement for uniform RF deliveryFDA Cleared$1,000–$2,200/session
Secret RF (Cutera)CuteraSemi-insulated needles; different depth profileFDA Cleared$900–$1,800/session
Quick Facts
Duration12–18 months
Studies250+
FDA StatusFDA Cleared (510k)
Price$800–$2,000/session
Full list of studies reviewed
30 studies +
  1. 1.DiBernardo BE, Pozner JN. Intense pulsed light therapy for skin rejuvenation. Clin Plast Surg. 2016;43(3):535-40.
  2. 2.Hantash BM, Ubeid AA, Chang H, Kafi R, Renton B. Bipolar fractional radiofrequency treatment induces neoelastogenesis and neocollagenesis. Lasers Surg Med. 2009;41(1):1-9.PMID 27363767
  3. 3.Alexiades M, Berube D. Randomized, blinded, 3-arm clinical trial assessing optimal temperature and duration for treatment with minimally invasive fractional radiofrequency. Dermatol Surg. 2015;41(5):623-32.PMID 19143021
  4. 4.Weiss RA, Weiss MA, Munavalli G, Beasley KL. Monopolar radiofrequency facial tightening: a retrospective analysis of efficacy and safety in over 600 treatments. J Drugs Dermatol. 2006;5(8):707-12.PMID 25915628
  5. 5.Lolis MS, Goldberg DJ. Radiofrequency in cosmetic dermatology: a review. Dermatol Surg. 2012;38(11):1765-76.PMID 16989184
  6. 6.Shin JW, Kwon SH, Kim SY, Park KC, Shin SW, Chung WS. Characteristics of adipose-derived stromal/stem cells from patients treated with fractional radiofrequency. Lasers Med Sci. 2015;30(8):2161-6.
  7. 7.Gold MH, Biron JA. Treatment of acne scars by fractional bipolar radiofrequency energy. J Cosmet Laser Ther. 2012;14(4):172-8.PMID 22352353
  8. 8.Nguyen L, et al. Radiofrequency Microneedling for Skin Tightening of the Lower Face, Jawline, and Neck Region. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]. 2022.PMID 22548644
  9. 9.Unknown. Consensus Recommendations for 4th Generation Non-Microneedling Monopolar Radiofrequency for Skin Tightening: A Delphi Consensus Panel. Journal of drugs in dermatology : JDD. 2020.PMID 41566557
  10. 10.Nilforoushzadeh MA, et al. Biometric changes of skin parameters in using of microneedling fractional radiofrequency for skin tightening and rejuvenation facial. Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI). 2020.PMID 32585051
  11. 11.Sturm A, et al. Nonsurgical Rejuvenation of the Neck. Facial plastic surgery clinics of North America. 2022.PMID 35934442
  12. 12.Liu Y, et al. Facial tightening using a novel vacuum-assisted microneedle fractional radiofrequency system: A prospective, randomized, split-face study. Journal of cosmetic dermatology. 2024.PMID 38923679
  13. 13.Kumar N, et al. Radiofrequency Microneedling for Facial Rejuvenation: A Systematic Review. Journal of cosmetic dermatology. 2026.PMID 41947517
  14. 14.Shauly O, et al. Radiofrequency Microneedling: Technology, Devices, and Indications in the Modern Plastic Surgery Practice. Aesthetic surgery journal. Open forum. 2023.PMID 41947517
  15. 15.Sadick N, et al. Minimally Invasive Radiofrequency Devices. Clinics in plastic surgery. 2016.PMID 27363771
  16. 16.Fritz K, et al. Ways of Noninvasive Facial Skin Tightening and Fat Reduction. Facial plastic surgery : FPS. 2016.PMID 27363771
  17. 17.Oh S, et al. Real-World Clinical Practice on Skin Rejuvenation Among Korean Board-Certified Dermatologists: Survey-Based Results. Annals of dermatology. 2025.PMID 27248025
  18. 18.Gentile RD, et al. Radiofrequency Technology in Face and Neck Rejuvenation. Facial plastic surgery clinics of North America. 2018.PMID 40432360
  19. 19.Chao JR, et al. Cosmetic Treatments with Energy-Based Devices in Skin of Color. Facial plastic surgery : FPS. 2023.PMID 37557909
  20. 20.Kaplan H, et al. Combination of microneedle radiofrequency (RF), fractional RF skin resurfacing and multi-source non-ablative skin tightening for minimal-downtime, full-face skin rejuvenation. Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology. 2016.PMID 37557909
  21. 21.Kleidona IA, et al. Fractional radiofrequency in the treatment of skin aging: an evidence-based treatment protocol. Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology. 2020.PMID 31825296
  22. 22.Nguyen L, et al. Radiofrequency Microneedling With 1927 nm Thulium Laser Versus Radiofrequency Microneedling Monotherapy for Rejuvenation of Photoaged Skin. Journal of cosmetic dermatology. 2026.PMID 41566557
  23. 23.Huang L, et al. Efficiency and safety of microneedling fractional radiofrequency in the treatment of Chinese atrophic acne scars: A retrospective study of 3 consecutive treatments with 1-month intervals. Journal of cosmetic dermatology. 2023.PMID 41566557
  24. 24.Waldorf HA, et al. Pin-Based Fractional Radiofrequency: 2024 International Consensus Recommendations for Aesthetic Skin Indications. Journal of drugs in dermatology : JDD. 2025.PMID 36217740
  25. 25.Kwon HH, et al. Novel device-based acne treatments: comparison of a 1450-nm diode laser and microneedling radiofrequency on mild-to-moderate acne vulgaris and seborrhoea in Korean patients through a 20-week prospective, randomized, split-face study. Journal of the European Academy of Dermatology and Venereology : JEADV. 2018.PMID 40773612
  26. 26.Hendel K, et al. Fractional CO(2) -laser versus microneedle radiofrequency for acne scars: A randomized, single treatment, split-face trial. Lasers in surgery and medicine. 2023.PMID 36934435
  27. 27.Kroepfl L, et al. Combination Therapy for Acne Scarring: Personal Experience and Clinical Suggestions. Journal of drugs in dermatology : JDD. 2016.PMID 28095556
  28. 28.Kupwiwat R, et al. Transdermal Delivery of Poly-L-Lactic Acid via Fractional Microneedle Radiofrequency for Atrophic Acne Scars: A Split-Face Randomized Study in Fitzpatrick Skin Types III to V. Dermatology and therapy. 2026.PMID 28095556
  29. 29.Vejjabhinanta V, et al. The efficacy in treatment of facial atrophic acne scars in Asians with a fractional radiofrequency microneedle system. Journal of the European Academy of Dermatology and Venereology : JEADV. 2014.PMID 25158223
  30. 30.Velázquez Arenas LL, et al. Multimodal Management of Facial Acne Scarring Using Energy-Based Devices and Injectable Therapies: A Case Report. Cureus. 2026.PMID 25158223

Should You Try This?

15106OUT OF 10

Probably wait for more data

Questions to ask your doctor

  • Q1

    What depth settings do you plan for this area, and what energy level?

    Good answer

    A good answer gives specific numbers tied to your anatomy: "For the face I typically use 3 to 4 millimetres depth. For the neck or body, I go deeper, around 5 to 7 millimetres. Energy is set based on tissue resistance at that depth." The depth matters because going too shallow wastes the treatment, and going too deep into the fat layer can cause adipose atrophy, which means fat loss that can make you look hollower rather than tighter. A provider who says "standard setting" without adjusting for your anatomy is not accounting for the primary cause of this complication.

  • Q2

    What results should I expect at 6 weeks, 3 months, 6 months?

    Good answer

    A good answer is specific and honest about the timeline: "At six weeks you will notice some early tightening from collagen contraction. At three months is when most patients see the peak improvement. By six months the result has stabilised." Anything visible right after treatment is temporary swelling or transient contraction, not lasting remodelling. An injector who promises dramatic improvement in the first few weeks, or who says the full result is visible immediately, is misrepresenting how collagen remodelling works.

  • Q3

    How do you minimise the risk of adipose atrophy?

    Good answer

    A good answer shows they understand the mechanism: "I keep my needle depth conservative in areas where there is not much subcutaneous fat, so the energy does not reach into the fat layer. I avoid stacking multiple high-energy passes over the same spot, and I adjust settings down for patients who are leaner." Adipose atrophy means loss of fat tissue in the treated area, which can leave you looking hollower rather than lifted. If they seem unfamiliar with this complication, that is a knowledge gap for a provider offering this treatment at the settings needed for clinical results.

  • Q4

    How many sessions do you recommend?

    Good answer

    A good answer follows the published evidence: "Three sessions spaced four to six weeks apart for initial treatment, then annual maintenance. That is what the clinical data supports." A provider who recommends more than four sessions in a first series without a specific clinical rationale may be over-treating. A provider who says one session is enough for meaningful laxity correction is likely underdelivering the protocol needed for results.

  • Q5

    What topical numbing protocol do you use, and how long before the treatment?

    Good answer

    A good answer is specific about timing: "We apply a prescription-strength numbing cream at least 45 to 60 minutes before treatment. For higher-energy sessions or more sensitive patients, we may also use nerve blocks." Morpheus8 is genuinely uncomfortable without adequate numbing. Clinics that apply over-the-counter numbing for 15 to 20 minutes are not providing adequate pain management for this procedure, which directly affects whether you will tolerate the settings needed for a meaningful result.

Clinic checklist

Universal

  • Check the practitioner is licensed and registered. In the UK: look them up on the GMC (doctors), NMC (nurses), or GDC (dentists) register, all free to search online. In the US: search your state medical board. Takes 2 minutes. If they cannot tell you their regulatory body, leave.
  • Ask to see the product box before treatment. It should be factory-sealed with a visible lot number and expiry date. If the product arrives pre-drawn in a syringe with no packaging, you cannot verify what you are being injected with.
  • You should receive a written consent form before treatment. It should name the specific product, list the known risks, and state what the clinic will do if complications arise. A single generic form with no product name is not adequate.
  • A reputable clinic will ask about your current medications (especially blood thinners like aspirin, ibuprofen, warfarin), supplements (fish oil, vitamin E, ginkgo), autoimmune conditions, allergies, and past treatments. If no one asks, they are skipping a safety step.
  • Before photos should be taken in consistent lighting before every session. This protects you: if a complication or asymmetry develops, both you and the clinic have a documented baseline. If a clinic does not take before photos, they are not tracking outcomes.
  • Get the full cost in writing before agreeing to treatment, including follow-up visits, touch-up appointments, and what the clinic charges for managing complications. Verbal quotes are not binding.

Procedure-specific

  • Ask: what depth settings do you plan for this area, and how do you avoid adipose atrophy? Adipose atrophy means fat loss in the treated area, which can leave you looking hollower rather than tighter. The risk increases when needle depth is too shallow in areas with limited fat, or when multiple high-energy passes are stacked over the same point. An injector who seems unfamiliar with this complication has a knowledge gap for a treatment they are offering.
  • Ask: is the device you are using genuine InMode Morpheus8? Grey-market fractional RF devices with similar names exist. Genuine devices have a specific serial number and InMode-issued treatment tips. The clinical evidence applies to the genuine device only.

Educational content only. This page summarises published clinical research and is not medical advice. Consult a qualified healthcare provider before making decisions about your care.

Researched by

Val Yermakova

Informed Girl · informedgirl.com